Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients

Atypical Antipsychotic-Induced Weight Gain

(2011) James L. Roerig et al.   CNS DRUGS

Serotonin 2A receptor antagonists for treatment of schizophrenia

(2011) Bjørn H Ebdrup et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Decreased Frontal Serotonin2A Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia

(2010) Hans Rasmussen et al.   ARCHIVES OF GENERAL PSYCHIATRY

Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia

(2010) Bjorn Ebdrup   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine

(2010) Hans Rasmussen et al.   PSYCHOPHARMACOLOGY

Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET

(2009) Matthias M. Herth et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes

(2009) CHRISTOPH U. CORRELL et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use

(2009) D. Erritzoe et al.   NEUROIMAGE

Serotonin Receptors

(2008) David E. Nichols et al.   CHEMICAL REVIEWS

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET